Difference between revisions of "20.109(S17):Analyze RNA-seq data (Day7)"
From Course Wiki
MAXINE JONAS (Talk | contribs) (→Protocols) |
Noreen Lyell (Talk | contribs) (→Protocols) |
||
| Line 1: | Line 1: | ||
{{Template:20.109(S17)}} | {{Template:20.109(S17)}} | ||
<div style="padding: 10px; width: 790px; border: 5px solid #6633CC;"> | <div style="padding: 10px; width: 790px; border: 5px solid #6633CC;"> | ||
| + | |||
| + | ==Introduction== | ||
| + | Today you will analyze the RNA-seq data gathered from untreated DLD-1 and BRCA2- cells and etoposide treated DLD-1 and BRCA2- cells. Following RNA purification, the samples were submitted to the BioMicro Center for Illumina sequencing. Illumina sequencing technology, or sequencing by synthesis (SBS), is used for massively parallel sequencing with a proprietary method that detects single bases as they are incorporated into growing DNA strands. | ||
==Protocols== | ==Protocols== | ||
Revision as of 02:07, 3 April 2017
Introduction
Today you will analyze the RNA-seq data gathered from untreated DLD-1 and BRCA2- cells and etoposide treated DLD-1 and BRCA2- cells. Following RNA purification, the samples were submitted to the BioMicro Center for Illumina sequencing. Illumina sequencing technology, or sequencing by synthesis (SBS), is used for massively parallel sequencing with a proprietary method that detects single bases as they are incorporated into growing DNA strands.
Protocols
Analysis of RNA-Seq data (DLD-1 / BRCA2-/- cells' transcripts, +/- etoposide) by Amanda Kedaigle, Prof. Ernest Fraenkel & Prof. Leona Samson.
Next day: Journal club II
Previous day: Practice data analysis methods